{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:27:51Z","timestamp":1789921671877,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Epidemiology (SFO), Karolinska Institutet"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejca.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T17:01:51Z","timestamp":1501866111000},"page":"60-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Menopausal hormone therapy and cancer risk: An overestimated risk?"],"prefix":"10.1016","volume":"84","author":[{"given":"Johanna","family":"Simin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulla","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Olov","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-447X","authenticated-orcid":false,"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.07.012_bib1","series-title":"The Swedish medical products agency (L\u00e4kemedelsverket)","year":"2017"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.012_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.maturitas.2014.07.002","article-title":"Menopausal hormone therapy use in 17 European countries during the last decade","volume":"79","author":"Ameye","year":"2014","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.012_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00042192-200007040-00010","article-title":"Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study","volume":"7","author":"Li","year":"2000","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.012_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/13697130400001786","article-title":"A longitudinal population study of climacteric symptoms and their treatment in a random sample of Swedish women","volume":"7","author":"Thunell","year":"2004","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.012_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.012_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jech.2005.033316","article-title":"Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives","volume":"59","author":"Krieger","year":"2005","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.012_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrendo.2016.164","article-title":"Hormone-replacement therapy: current thinking","volume":"13","author":"Lobo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.012_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMp1514242","article-title":"Menopause management\u2013getting clinical care back on track","volume":"374","author":"Manson","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejca.2017.07.012_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/13697130802716056","article-title":"Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women","volume":"12","author":"Fournier","year":"2009","journal-title":"Climacteric"},{"issue":"6","key":"10.1016\/j.ejca.2017.07.012_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/humupd\/dmi031","article-title":"Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials","volume":"11","author":"Greiser","year":"2005","journal-title":"Hum Reprod Update"},{"issue":"9980","key":"10.1016\/j.ejca.2017.07.012_bib11","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejca.2017.07.012_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.7.872","article-title":"Postmenopausal hormone replacement therapy: scientific review","volume":"288","author":"Nelson","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejca.2017.07.012_bib13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.30588","article-title":"Menopausal hormone therapy and the risk of esophageal and gastric cancer","volume":"140","author":"Brusselaers","year":"2017","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.012_bib14","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/ijc.28869","article-title":"Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis","volume":"135","author":"Lagergren","year":"2014","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2017.07.012_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/dote.12349","article-title":"Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis","volume":"29","author":"Wang","year":"2016","journal-title":"Dis Esophagus"},{"issue":"10","key":"10.1016\/j.ejca.2017.07.012_bib16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/ijc.26236","article-title":"Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis","volume":"130","author":"Green","year":"2012","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2017.07.012_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ijc.26026","article-title":"The effect of oestrogen vs. combined oestrogen-progestogen therapy on the risk of colorectal cancer","volume":"130","author":"Lin","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2017.07.012_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/2050640617702060","article-title":"Menopausal hormone therapy and pancreatic cancer risk in women","author":"Sadr-Azodi","year":"2017","journal-title":"UEG"},{"issue":"8","key":"10.1016\/j.ejca.2017.07.012_bib19","doi-asserted-by":"crossref","first-page":"e71236","DOI":"10.1371\/journal.pone.0071236","article-title":"Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis","volume":"8","author":"Yao","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.012_bib20","doi-asserted-by":"crossref","first-page":"e0118868","DOI":"10.1371\/journal.pone.0118868","article-title":"Significant reduction of antibiotic consumption and patients' costs after an action plan in China, 2010\u20132014","volume":"10","author":"Bao","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.012_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.maturitas.2009.11.027","article-title":"Menopausal hormone therapy and risk of lung cancer-systematic review and meta-analysis","volume":"65","author":"Greiser","year":"2010","journal-title":"Maturitas"},{"issue":"17","key":"10.1016\/j.ejca.2017.07.012_bib22","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ejca.2011.04.023","article-title":"Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis","volume":"47","author":"Gandini","year":"2011","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.012_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10552-015-0546-z","article-title":"Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies","volume":"26","author":"Caini","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.012_bib24","doi-asserted-by":"crossref","first-page":"e0138556","DOI":"10.1371\/journal.pone.0138556","article-title":"Hormone replacement therapy, likely neither angel nor demon","volume":"10","author":"Wachtel","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejca.2017.07.012_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish prescribed drug register\u2013opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.ejca.2017.07.012_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.012_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/jech.56.4.301","article-title":"Comparing hospital discharge records with death certificates: can the differences be explained?","volume":"56","author":"Johansson","year":"2002","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"10.1016\/j.ejca.2017.07.012_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2017.07.012_bib29","unstructured":"Socialstyrelsen. Cancerincidence i Sverige 2014. Socialstyrelsen, december 2015; 2015. Report No.: 2014-12-26."},{"key":"10.1016\/j.ejca.2017.07.012_bib30","series-title":"Statistical methods in cancer research","author":"Breslow","year":"1987"},{"issue":"12","key":"10.1016\/j.ejca.2017.07.012_bib31","first-page":"E1","article-title":"Hormone therapy for menopausal symptoms: putting benefits and risks into perspective","volume":"59","author":"Warren","year":"2010","journal-title":"J Fam Pract"},{"issue":"7 Suppl. 1","key":"10.1016\/j.ejca.2017.07.012_bib32","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","article-title":"Postmenopausal hormone therapy: an Endocrine Society scientific statement","volume":"95","author":"Santen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejca.2017.07.012_bib33","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1136\/bmj.e763","article-title":"Hormone replacement therapy","volume":"344","author":"Hickey","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejca.2017.07.012_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/13697137.2016.1196047","article-title":"Revised global consensus statement on menopausal hormone therapy","volume":"19","author":"de Villiers","year":"2016","journal-title":"Climacteric"},{"issue":"30\u201331","key":"10.1016\/j.ejca.2017.07.012_bib35","first-page":"2167","article-title":"Vaginala v\u00e4gen vinner vid hysterektomi","volume":"104","author":"Flam","year":"2007","journal-title":"L\u00e4kartidningen"},{"issue":"1","key":"10.1016\/j.ejca.2017.07.012_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/00016340802596017","article-title":"Hysterectomy on benign indications in Sweden 1987\u20132003: a nationwide trend analysis","volume":"88","author":"Lundholm","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9639","key":"10.1016\/j.ejca.2017.07.012_bib37","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(08)61255-6","article-title":"Declining breast cancer incidence and decreased HRT use","volume":"372","author":"Kumle","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2017.07.012_bib38","unstructured":"Li C, Samsioe G Fau, Lidfelt J, Lidfelt J Fau - Nerbrand C, Nerbrand C Fau - Agardh CD, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. (1072\u20133714 (Print))."},{"issue":"5","key":"10.1016\/j.ejca.2017.07.012_bib39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/01.AOG.0000285997.38553.4b","article-title":"Hysterectomy rates in the United States, 2003","volume":"110","author":"Wu","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.012_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/GME.0000000000000294","article-title":"Use of hormone therapy in Swedish women aged 80 years or older","volume":"22","author":"Jarvstrat","year":"2015","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.ejca.2017.07.012_bib41","first-page":"1209","article-title":"Menopausal symptoms in older women and the effects of treatment with hormone therapy","volume":"100","author":"Barnabei","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejca.2017.07.012_bib42","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.30588","article-title":"Menopausal hormone therapy and the risk of esophageal and gastric cancer","volume":"140","author":"Brusselaers","year":"2017","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.012_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.annepidem.2014.11.008","article-title":"What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking?","volume":"25","author":"Jacobs","year":"2015","journal-title":"Ann Epidemiol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2017.07.012_bib44","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/bjc.2011.475","article-title":"2. Tobacco-attributable cancer burden in the UK in 2010","volume":"105","author":"Parkin","year":"2011","journal-title":"Br J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491731122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491731122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T20:23:31Z","timestamp":1659299011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491731122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":44,"alternative-id":["S095980491731122X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.012","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopausal hormone therapy and cancer risk: An overestimated risk?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}